ValiRx plc (LON:VAL – Get Free Report) passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of GBX 0.21 and traded as low as GBX 0.13. ValiRx shares last traded at GBX 0.14, with a volume of 2,958 shares.
ValiRx Price Performance
The company has a market capitalization of £1.72 million, a PE ratio of -0.24 and a beta of 0.59. The stock has a 50-day moving average of GBX 0.15 and a 200 day moving average of GBX 0.21.
ValiRx (LON:VAL – Get Free Report) last issued its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) EPS for the quarter. ValiRx had a negative return on equity of 71.49% and a negative net margin of 6,548.06%. Equities analysts forecast that ValiRx plc will post -1.74 EPS for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
